What If This Isn’t for You But for Someone You Can’t Afford to Lose?
Maybe your heart’s fine. Maybe you’re young, healthy, active. You eat spinach, hit the gym, even remember to hydrate.
But what about your dad? Your aunt? Your best friend who skips checkups? Or the coworker who swears that chest pain is just “stress”?
Because here’s the truth: This might not be for you but it could save someone you love.
We Can’t Help, We Didn’t Catch It in Time
That’s what too many people hear in the ER, Arrhythmia doesn’t show up on command. It comes and goes, usually when you’re not wearing that 2-week patch monitor. And by the time something serious happens… the data’s missing.
Future Cardia was built to fix that.
It’s a tiny implantable monitor inserted in 2 minutes, no hospital required that tracks heart rhythm continuously for two years straight. No recharging, no fuss, no more guesswork.
It’s already been implanted in 39 patients, tested in top U.S. clinics, and collected over 60,000 hours of real-world heart data.
And the company behind it?
- Backed by Stanford StartX and Johnson & Johnson’s JLABS
- Led by a CEO who’s worked in cardiac care for 20+ years
- Supported by investors with $1B+ exits in medtech and remote monitoring
Why Now? Why You?
Because this isn’t some distant idea.
Future Cardia is on track to submit to the FDA by the end of this year, the round closes June 18. You can still invest, for now.
Minimum is $348, that’s less than what you’d spend on a long weekend or your favorite “funny but overpriced” smartwatch.
So maybe it’s not for you.
But maybe it’s for someone who never says anything until it’s too late, maybe it’s for the person in your life who’s always taking care of others but needs someone (like you) to look out for them.
Share This, Seriously
If you don’t invest, that’s okay. But if someone you love needs this, send them this article.
Text or email it to your mom, email it to your friend who skips physicals, and drop it in the group chat.
Because the people who need this the most? They usually don’t ask for it, but they deserve it anyway.
*This product is not yet available for purchase and requires review and clearance before being marketed or sold. This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.